MassMutual Private Wealth & Trust’s Seres Therapeutics MCRB Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-46	Closed	-$2.17K	–	2031
2023 Q3	$2.17K	Hold	46	–	–	﹤0.01%	1485
2023 Q2	$4.38K	Buy	+46	New	+$5.01K	﹤0.01%	1249
2022 Q2	–	Sell	-17	Closed	-$2K	–	1632
2022 Q1	$2K	Hold	17	–	–	﹤0.01%	1172
2021 Q4	$3K	Hold	17	–	–	﹤0.01%	1010
2021 Q3	$2K	Hold	17	–	–	﹤0.01%	1067
2021 Q2	$8K	Hold	17	–	–	﹤0.01%	724
2021 Q1	$7K	Hold	17	–	–	﹤0.01%	660
2020 Q4	$9K	Buy	+17	New	+$9.96K	﹤0.01%	617

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MassMutual Private Wealth & Trust's MCRB Position: Q4 2023 in Review

MassMutual Private Wealth & Trust sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 46 shares — an estimated $2.17K sold.

MassMutual Private Wealth & Trust first reported a position in MCRB in Q4 2020 and held it in 8 quarters. The position peaked at $9K in Q4 2020. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

MassMutual Private Wealth & Trust reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 46 Seres Therapeutics shares in Q4 2023, an estimated $2.17K.
MassMutual Private Wealth & Trust first reported a position in Seres Therapeutics in Q4 2020 and held it in 8 quarters.
MassMutual Private Wealth & Trust's Seres Therapeutics position peaked at $9K in Q4 2020.
102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2023, filed 3 Jan 2024.